Target intelligence / Profile preview

M-phase-specific PLK1-interacting protein (MPLKIP)

Target
MPLKIP
Molecular classification
Other (nuclear protein, cell cycle-associated protein)
01

Overview

The M-phase-specific PLK1-interacting protein (MPLKIP) is a nuclear protein encoded by the MPLKIP gene, previously known as C7orf11 or TTDN1. This protein localizes to the centrosome during mitosis and to the midbody during cytokinesis, where it is phosphorylated by cyclin-dependent kinase 1 and interacts with polo-like kinase 1 (PLK1)[1][3][4][5][7]. MPLKIP is implicated in the regulation of mitosis and cytokinesis, and its loss disrupts the integrity of the mitotic spindle and cell division. Beyond cell cycle functions, MPLKIP interacts with core splicing factors and with the RNA lariat debranching enzyme DBR1, stabilizing DBR1 and promoting efficient mRNA splicing[2]. Mutations in MPLKIP cause the autosomal recessive disorder non-photosensitive trichothiodystrophy (TTD), characterized by brittle hair, developmental issues, and multisystem involvement, without sensitivity to UV light[1][3][4][5]. There is currently no evidence that MPLKIP is a therapeutic target, nor are there known drugs that modulate its activity. Its primary clinical relevance is as a causative gene in non-photosensitive TTD, rather than as a pharmacologically actionable protein.

Other names
ABHSC7orf11chromosome 7 open reading frame 11ORF20TTDN1TTD non-photosensitive 1 proteinTTD4Russell-Silver syndrome region
02

Biological functions

Cell cycle regulationCytokinesisMitotic spindle assemblymRNA splicingProtein stability
03

Disease associations

Other (non-photosensitive trichothiodystrophy)Developmental disorder

Beyond the preview

Go deeper on M-phase-specific PLK1-interacting protein (MPLKIP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on M-phase-specific PLK1-interacting protein (MPLKIP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call